CDSCO Panel Grants AstraZeneca's Protocol Amendment Proposal for Anifrolumab Dr. Divya Colin4 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation CDSO has approved the drug major's...
CDSCO panel Approves Pfizer's Protocol Amendment Proposal for Anti-cancer Drug Elranatamab Dr. Divya Colin2 Jan 2024 5:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Pfizer's Proposal for protocol amendment of Marstacimab Dr. Divya Colin1 Jan 2024 5:30 PM ISTNew Delhi: The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Grants Novartis Protocol Amendment For Ofatumumab Dr. Divya Colin31 Dec 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel grants AstraZeneca's Protocol Amendment Proposal for Sodium zirconium cyclosilicate Dr. Divya Colin31 Dec 2023 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Submit Justification and Rational: CDSCO Panel tells Pfizer on protocol amendment proposal for Palbociclib Dr. Divya Colin20 Dec 2023 6:25 PM ISTNew Delhi: In response to the proposal presented by the drug major Pfizer for the protocol amendment, the Subject Expert Committee (SEC) functional...
CDSCO Panel Approves Sanofi's Protocol Amendment Proposal for SAR443122 Dr. Divya Colin2 July 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
CDSCO Panel Approves Roche's Protocol Amendment Proposal to Study Polatuzumab Vedotin Dr. Divya Colin2 July 2023 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has approved the protocol amendment...
IQVIA gets CDSCO panel okay to reopen trial recruitment in the country for Evobrutinib Dr. Divya Colin26 Oct 2022 1:30 PM ISTNew Delhi: Approving IQVIA proposal to amend Phase III Clinical Trail protocol of Bruton's tyrosine kinase (BTK) inhibitor Evobrutinib, the Subject...
AstraZeneca anticancer drug Trastuzumab Deruxtecan protocol amendment proposal approved by CDSCO panel Roshni Dhar23 Aug 2022 6:30 PM ISTBased on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug Standard Control...
